betaine has been researched along with Dementia Praecox in 5 studies
glycine betaine : The amino acid betaine derived from glycine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kirihara, K | 3 |
| Fujioka, M | 3 |
| Suga, M | 3 |
| Kondo, S | 3 |
| Ichihashi, K | 3 |
| Koshiyama, D | 3 |
| Morita, K | 3 |
| Ikegame, T | 4 |
| Tada, M | 3 |
| Araki, T | 3 |
| Jinde, S | 3 |
| Taniguchi, K | 3 |
| Hosokawa, T | 3 |
| Sugishita, K | 3 |
| Dogan, S | 3 |
| Marumo, K | 3 |
| Itokawa, M | 3 |
| Kasai, K | 4 |
| Murata, Y | 1 |
| Koike, S | 1 |
| Saito, T | 1 |
| Ikeda, M | 1 |
| Sasaki, T | 1 |
| Iwata, N | 1 |
| Bundo, M | 1 |
| Iwamoto, K | 1 |
| Yoshihara, S | 1 |
| Jiang, X | 1 |
| Morikawa, M | 1 |
| Ogawa, T | 1 |
| Ichinose, S | 1 |
| Yabe, H | 2 |
| Kakita, A | 2 |
| Toyoshima, M | 2 |
| Kunii, Y | 2 |
| Yoshikawa, T | 2 |
| Tanaka, Y | 1 |
| Hirokawa, N | 1 |
| Ohnishi, T | 1 |
| Balan, S | 1 |
| Maekawa, M | 1 |
| Ohba, H | 1 |
| Watanabe, A | 1 |
| Iwayama, Y | 1 |
| Fujita, Y | 1 |
| Tan, Y | 1 |
| Hisano, Y | 1 |
| Shimamoto-Mitsuyama, C | 1 |
| Nozaki, Y | 1 |
| Esaki, K | 1 |
| Nagaoka, A | 1 |
| Matsumoto, J | 1 |
| Hino, M | 1 |
| Mataga, N | 1 |
| Hayashi-Takagi, A | 1 |
| Hashimoto, K | 1 |
| Gentili, C | 1 |
| Borghesi, E | 1 |
5 other studies available for betaine and Dementia Praecox
| Article | Year |
|---|---|
Betaine supplementation improves positive symptoms in schizophrenia.
Topics: Betaine; Dietary Supplements; Homocysteine; Humans; Methionine; Schizophrenia | 2022 |
Betaine supplementation improves positive symptoms in schizophrenia.
Topics: Betaine; Dietary Supplements; Homocysteine; Humans; Methionine; Schizophrenia | 2022 |
Betaine supplementation improves positive symptoms in schizophrenia.
Topics: Betaine; Dietary Supplements; Homocysteine; Humans; Methionine; Schizophrenia | 2022 |
Betaine supplementation improves positive symptoms in schizophrenia.
Topics: Betaine; Dietary Supplements; Homocysteine; Humans; Methionine; Schizophrenia | 2022 |
Betaine supplementation improves positive symptoms in schizophrenia.
Topics: Betaine; Dietary Supplements; Homocysteine; Humans; Methionine; Schizophrenia | 2022 |
Betaine supplementation improves positive symptoms in schizophrenia.
Topics: Betaine; Dietary Supplements; Homocysteine; Humans; Methionine; Schizophrenia | 2022 |
Betaine supplementation improves positive symptoms in schizophrenia.
Topics: Betaine; Dietary Supplements; Homocysteine; Humans; Methionine; Schizophrenia | 2022 |
Betaine supplementation improves positive symptoms in schizophrenia.
Topics: Betaine; Dietary Supplements; Homocysteine; Humans; Methionine; Schizophrenia | 2022 |
Betaine supplementation improves positive symptoms in schizophrenia.
Topics: Betaine; Dietary Supplements; Homocysteine; Humans; Methionine; Schizophrenia | 2022 |
Global DNA hypomethylation and its correlation to the betaine level in peripheral blood of patients with schizophrenia.
Topics: Adult; Betaine; Biomarkers; DNA Methylation; Female; Humans; Male; Schizophrenia; Schizophrenic Psyc | 2020 |
Betaine ameliorates schizophrenic traits by functionally compensating for KIF3-based CRMP2 transport.
Topics: Actins; Animals; Behavior, Animal; Betaine; Biological Transport; Diet; Disease Models, Animal; Gene | 2021 |
Investigation of betaine as a novel psychotherapeutic for schizophrenia.
Topics: Animals; Betaine; Brain; Choline Dehydrogenase; Dietary Supplements; Disease Models, Animal; DNA Met | 2019 |
[Remarks on the level of transmethylases in schizophrenic patients. In vitro assays].
Topics: Betaine; Humans; In Vitro Techniques; Methylation; Niacinamide; Schizophrenia | 1967 |